4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims/hypothesis

          This study aimed to explore the infancy growth trajectories of ‘recent’ and ‘earlier’ offspring of mothers with gestational diabetes mellitus (OGDM), each compared with the same control infants, and investigate whether ‘recent’ OGDM still exhibit a classical phenotype, with macrosomia and increased adiposity.

          Methods

          Within a prospective observational birth cohort, 98 ‘earlier’ OGDM born between 2001 and 2009 were identified using 75 g oral glucose tolerance testing at 28 weeks gestation, 122 recent OGDM born between 2011 and 2013 were recruited postnatally through antenatal diabetes clinics, and 876 normal birthweight infants of mothers with no history of diabetes were recruited across the full study period as the control group. All infants followed the same study protocol (measurements at birth, 3, 12 and 24 months, including weight, length and skinfold thickness indicating adiposity, and detailed demographic data). In all cases, GDM was defined using the International Association of Diabetes and Pregnancy Study Group criteria.

          Results

          Earlier OGDM had higher birthweight SD scores (SDS) than control infants. Conversely, recent OGDM had similar birthweight- and length SDS to control infants (mean ± SD, 0.1 ± 1.0 and− 0.1 ± 0.9, respectively), but lower mean skinfold thickness SDS (−0.4 ± 0.6 vs 0.0 ± 0.9; p < 0.001). After birth, earlier OGDM showed reduced gains in weight and length between 3 and 12 months. In contrast, recent OGDM had increased weight and skinfold thickness gains until 3 months, followed by reduced gains in those variables from 3 to 12 months, compared with control infants. At 24 months, recent OGDM had lower adiposity than control infants (mean skinfold thickness SDS −0.3 ± 0.7 vs 0.0 ± 0.8; p < 0.001). At all time points recent OGDM had lower growth measurements than earlier OGDM.

          Conclusions/interpretation

          Recent OGDM showed different growth trajectories to the earlier group, namely normalisation of birthweight and reduced adiposity at birth, followed by initial rapid weight gain but subsequent reduced adiposity postnatally. While avoidance of macrosomia at birth may be advantageous, the longer-term health implications of these changing growth trajectories are uncertain.

          Electronic supplementary material

          The online version of this article (10.1007/s00125-019-4970-6) contains peer-reviewed but unedited supplementary material, which is available to authorised users.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Increased fetal adiposity: a very sensitive marker of abnormal in utero development.

          Because offspring of women with gestational diabetes mellitus have an increased risk of obesity and diabetes mellitus as young adults, our purpose was to characterize body composition at birth in infants of women with gestational diabetes mellitus and normal glucose tolerance. One hundred ninety-five infants of women with gestational diabetes mellitus and 220 infants of women with normal glucose tolerance had anthropometric measurements and total body electrical conductivity body composition evaluations at birth. Parental demographic, anthropometric, medical and family history data, and diagnostic glucose values were used to develop a stepwise regression model that related to fetal growth and body composition. There was no significant difference in birth weight (gestational diabetes mellitus [3398+/-550 g] vs normal glucose tolerance [3337+/-549 g], P=.26) or fat-free mass (gestational diabetes mellitus [2962+/-405 g] vs normal glucose tolerance [2975+/-408 g], P=.74) between groups. However, infants of women with gestational diabetes mellitus had significantly greater skinfold measures (P=.0001) and fat mass (gestational diabetes mellitus [436+/-206 g] vs normal glucose tolerance [362+/-198 g], P=.0002) compared with infants of women with normal glucose tolerance. In the gestational diabetes mellitus group, although gestational age had the strongest correlation with birth weight and fat-free mass, fasting glucose level had the strongest correlation with neonatal adiposity. Infants of women with gestational diabetes mellitus, even when they are average weight for gestational age, have increased body fat compared with infants of women with normal glucose tolerance. Maternal fasting glucose level was the strongest predictor of fat mass in infants of women with gestational diabetes mellitus. This increase in body fat may be a significant risk factor for obesity in early childhood and possibly in later life.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)

            OBJECTIVE In women with gestational diabetes mellitus, who were randomized to metformin or insulin treatment, pregnancy outcomes were similar (Metformin in Gestational diabetes [MiG] trial). Metformin crosses the placenta, so it is important to assess potential effects on growth of the children. RESEARCH DESIGN AND METHODS In Auckland, New Zealand, and Adelaide, Australia, women who had participated in the MiG trial were reviewed when their children were 2 years old. Body composition was measured in 154 and 164 children whose mothers had been randomized to metformin and insulin, respectively. Children were assessed with anthropometry, bioimpedance, and dual energy X-ray absorptiometry (DEXA), using standard methods. RESULTS The children were similar for baseline maternal characteristics and pregnancy outcomes. In the metformin group, compared with the insulin group, children had larger mid-upper arm circumferences (17.2 ± 1.5 vs. 16.7 ± 1.5 cm; P = 0.002) and subscapular (6.3 ± 1.9 vs. 6.0 ± 1.7 mm; P = 0.02) and biceps skinfolds (6.03 ± 1.9 vs. 5.6 ± 1.7 mm; P = 0.04). Total fat mass and percentage body fat assessed by bioimpedance (n = 221) and DEXA (n = 114) were not different. CONCLUSIONS Children exposed to metformin had larger measures of subcutaneous fat, but overall body fat was the same as in children whose mothers were treated with insulin alone. Further follow-up is required to examine whether these findings persist into later life and whether children exposed to metformin will develop less visceral fat and be more insulin sensitive. If so, this would have significant implications for the current pandemic of diabetes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy.

              We studied the relation in Pima Indians between obesity in children and diabetes during pregnancy in their mothers. Sixty-eight children of 49 women who had had diabetes during pregnancy had a higher prevalence of obesity than 541 children of 134 women who subsequently had diabetes (prediabetics) or than 1326 children of 446 women who remained nondiabetic. At 15 to 19 years of age, 58 per cent of the offspring of diabetics weighed 140 per cent or more of their desirable weight, as compared with 17 per cent of the offspring of nondiabetics and 25 per cent of those of prediabetics (P less than 0.001). Obesity in the offspring was directly related to maternal diabetes, since the association was not substantially confounded by maternal obesity. The findings strongly suggest that the prenatal environment of the offspring of diabetic women results in the development of obesity in childhood and early adulthood.
                Bookmark

                Author and article information

                Contributors
                dbd25@cam.ac.uk
                Journal
                Diabetologia
                Diabetologia
                Diabetologia
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0012-186X
                1432-0428
                9 August 2019
                9 August 2019
                2019
                : 62
                : 11
                : 1977-1987
                Affiliations
                [1 ]GRID grid.5335.0, ISNI 0000000121885934, Department of Paediatrics, , University of Cambridge, ; Box 116, Level 8, Cambridge Biomedical Campus, Cambridge, CB2 0QQ UK
                [2 ]GRID grid.439355.d, Present Address: Department of Paediatrics, , North Middlesex University Hospital NHS Trust, ; London, UK
                [3 ]GRID grid.24029.3d, ISNI 0000 0004 0383 8386, Wolfson Diabetes and Endocrine Clinic, , Cambridge University Hospitals NHS Foundation Trust, ; Cambridge, UK
                [4 ]GRID grid.1029.a, ISNI 0000 0000 9939 5719, Present Address: Macarthur Clinical School, , Western Sydney University, ; Sydney, NSW Australia
                [5 ]GRID grid.416391.8, Department of Diabetes and Endocrinology, , Norfolk and Norwich University Hospital, ; Norwich, UK
                [6 ]GRID grid.13097.3c, ISNI 0000 0001 2322 6764, Women’s Health Academic Centre, Division of Women’s and Children’s Health, , King’s College London, ; London, UK
                [7 ]GRID grid.470900.a, ISNI 0000 0004 0369 9638, MRC Epidemiology Unit, , Institute of Metabolic Science, ; Cambridge, UK
                [8 ]GRID grid.5335.0, ISNI 0000000121885934, Institute of Metabolic Science, , University of Cambridge, ; Cambridge, UK
                Article
                4970
                10.1007/s00125-019-4970-6
                6805804
                31396660
                09f9fbfd-ae4c-434c-8a21-73e23b6061bb
                © The Author(s) 2019

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 24 January 2019
                : 27 June 2019
                Funding
                Funded by: National Institute for Health Research Cambridge Biomedical Research Centre
                Funded by: Newlife Foundation for Disabled Children
                Award ID: 07/20
                Funded by: European Union Framework 5
                Award ID: QLK4-1999-01422
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: Unit programme: MC_UU_12015/2
                Funded by: World Cancer Research Fund International
                Award ID: 2004/03
                Funded by: Mothercare Charitable Foundation
                Award ID: RG54608
                Categories
                Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2019

                Endocrinology & Diabetes
                adiposity,gestational diabetes mellitus,growth,infancy,macrosomia,maternal hyperglycaemia,offspring,skinfold thickness,weight gain

                Comments

                Comment on this article